Abstract
Stimulator of interferon genes (STING) is a cellular sensor that controls cytosolic DNA-activated innate immune signaling. We have previously demonstrated that STING-deficient mice are resistant to carcinogen-induced skin cancer, similar to myeloid differentiation primary response gene 88 (MyD88) deficient mice, since the production of STING-dependent DNA-damage-induced proinflammatory cytokines, that likely require MyD88 signaling to exert their growth-promoting activity, are prevented. In contrast, MyD88-deficient mice are sensitive to colitis-associated cancer (CAC), since selected cytokines generated following DNA-damage also activate repair pathways, which can help prevent tumor development. Here, we demonstrate that STING signaling facilitates wound repair processes and that analogous to MyD88-deficient mice, STING-deficient mice (SKO) are prone to CAC induced by DNA-damaging agents. SKO mice harboring tumors exhibited low levels of tumor-suppressive interleukin-22 binding protein (IL-22BP) compared to normal mice, a cytokine considered critical for preventing colon-related cancer. Our data indicate that STING constitutes a critical component of the host early response to intestinal damage and is essential for invigorating tissue repair pathways that may help prevent tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
265,23 € per year
only 5,30 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Goldszmid RS, Trinchieri G . The price of immunity. Nat Immunol 2012; 13: 932–938.
Nowarski R, Gagliani N, Huber S, Flavell RA . Innate immune cells in inflammation and cancer. Cancer Immunol Res 2013; 1: 77–84.
Cataisson C, Salcedo R, Hakim S, Moffitt BA, Wright L, Yi M et al. IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis. J Exp Med 2012; 209: 1689–1702.
Ishikawa H, Ma Z, Barber GN . STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009; 461: 788–792.
Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011; 478: 515–518.
Cai X, Chiu YH, Chen ZJ . The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell 2014; 54: 289–296.
Ahn J, Ruiz P, Barber GN . Intrinsic self-DNA triggers inflammatory disease dependent on STING. J Immunol 2014; 193: 4634–4642.
Gall A, Treuting P, Elkon KB, Loo YM, Gale M Jr, Barber GN et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012; 36: 120–131.
Ahn J, Xia T, Konno H, Konno K, Ruiz P, Barber GN . Inflammation-driven carcinogenesis is mediated through STING. Nat Commun 2014; 5: 5166.
Salcedo R, Cataisson C, Hasan U, Yuspa SH, Trinchieri G . MyD88 and its divergent Toll in carcinogenesis. Trends Immunol 2013; 34: 379–389.
De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L et al. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog 2011; 10: 9.
Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012; 491: 259–263.
Ishikawa H, Barber GN . STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008; 455: 674–678.
Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med 2014; 371: 507–518.
Ahn J, Gutman D, Saijo S, Barber GN . STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci USA 2012; 109: 19386–19391.
Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 2011; 12: 270–279.
Jacoby RF, Llor X, Teng BB, Davidson NO, Brasitus TA . Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J Clin Invest 1991; 87: 624–630.
Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593–602.
Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci USA 2008; 105: 652–656.
Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med 2010; 207: 1625–1636.
Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA . Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008; 29: 947–957.
Rakoff-Nahoum S, Medzhitov R . Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007; 317: 124–127.
Zhu Q, Man SM, Gurung P, Liu Z, Vogel P, Lamkanfi M et al. Cutting edge: STING mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation. J Immunol 2014; 193: 4779–4782.
Fukata M, Vamadevan AS, Abreu MT . Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol 2009; 21: 242–253.
Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010; 207: 1045–1056.
Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011; 145: 745–757.
Acknowledgements
We thank Dr Masayuki Fukata for micro-endoscopy analysis; Ms Delia Gutman and Ms Auristela Rivera for mice breeding; Dr Tianli Xia for helping with confocal analysis; Dr Biju Issac of the Sylvester Comprehensive Cancer Center Bioinformatics Core Facility for Gene expression array analysis; Dr Phillp Ruiz and Ms Dayami Hernandez for helping with immunohistochemistry.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Ahn, J., Konno, H. & Barber, G. Diverse roles of STING-dependent signaling on the development of cancer. Oncogene 34, 5302–5308 (2015). https://doi.org/10.1038/onc.2014.457
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2014.457
This article is cited by
-
Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma
Oncogene (2024)
-
Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis
Scientific Reports (2022)
-
Cytosolic sensor STING in mucosal immunity: a master regulator of gut inflammation and carcinogenesis
Journal of Experimental & Clinical Cancer Research (2021)
-
MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model
Scientific Reports (2021)
-
Old dogs, new trick: classic cancer therapies activate cGAS
Cell Research (2020)